Wells Fargo’s DexCom DXCM Stock Holding History

Wells Fargo’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,900	Closed	-$1.45M	–	7258
2025 Q4	$1.45M	Hold	21,900	–	–	﹤0.01%	3681
2025 Q3	$1.47M	Hold	21,900	–	–	﹤0.01%	3542
2025 Q2	$1.91M	Sell	21,900 -150,000	-87%	-$11.8M	﹤0.01%	3247
2025 Q1	$11.7M	Buy	171,900 +150,000	+685%	+$12.2M	﹤0.01%	1737
2024 Q4	$1.7M	Hold	21,900	–	–	﹤0.01%	3322
2024 Q3	$1.47M	Buy	+21,900	New	+$1.8M	﹤0.01%	3285
2023 Q3	–	Sell	-34,700	Closed	-$4.46M	–	7602
2023 Q2	$4.46M	Buy	+34,700	New	+$4.2M	﹤0.01%	2235
2021 Q3	–	Sell	-450,400	Closed	-$48.1M	–	7051
2021 Q2	$48.1M	Buy	+450,400	New	+$43.3M	0.01%	1084

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo's DXCM Position: Q1 2026 in Review

Wells Fargo increased its DexCom (DXCM) stake by 4.2% in Q1 2026, buying an estimated $2.38M and bringing the position to 845,998 shares worth $53.1M. The position accounts for 0.01% of the portfolio, ranked #934.

Wells Fargo first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $546M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Wells Fargo held 845,998 shares of DexCom worth $53.1M as of Q1 2026.
Wells Fargo bought 34,127 DexCom shares in Q1 2026, an estimated $2.38M.
DexCom made up 0.01% of Wells Fargo's portfolio in Q1 2026, its #934 holding.
Wells Fargo first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's DexCom position peaked at $546M in Q3 2021.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.